期刊文献+

SDF-1/CXCR4在中青年乳腺癌中的表达及意义 被引量:1

Expression of SDF-1/CXCR4 in young and middle-aged patients and its significance.
原文传递
导出
摘要 目的探讨SDF-1/CXCR4在中青年乳腺癌中的表达与ER、PR、Her-2和BRCA1的表达以及肿瘤的组织病理学、淋巴结转移、5年存活率之间的关系,进一步探讨中青年乳腺癌的预后因素。方法采用原位分子杂交技术在乳腺浸润性导管癌中检测SDF-1基因;采用免疫组化方法,检测乳腺浸润性导管癌中CXCR4、ER、PR、Her-2和BRCA1的表达。结果在49例癌组织中,SDF-1、CXCR4阳性者分别为41和42例,阳性率为83.63%和85.61%,与PR的表达无明显相关性,与ER表达呈正相关,与Her-2表达呈正相关,与肿瘤的组织学分级有明显的相关性,即组织学分级越高,其表达越强。与淋巴结转移也呈明显的正相关,即淋巴结转移的病例阳性表达明显高于未转移病例。与病人的5年存活率呈负相关。结论SDF-1/CXCR4和Her-2高表达是中青年乳腺癌预后不良的重要指标。同时,SDF-1/CXCR4作为促进乳腺癌转移的关键性作用因子,成为了一个乳腺癌治疗的新的靶点。SDF-1/CXCR4与ER及Her-2的同时表达,预后更差。 Objective To investigate the expression of SDF-1/CXCR4 in middle-aged and young patients with infiltrating breast cancer and its correlation with the expression of ER,PR, Her-2 and BRCA1, pathologies of invading breast cancer,metastasis of lymphonodes and 5-years surviving rate. Methods The SDF-1 genes in 49 cases of breast carcinoma tissues aged 26 to 45 years were detected by hybridization in situ. CXCR4,ER,PR,Her-2 and BRCA1 were detected by immunohistochemistry. Results 41 out of 49 cases were positives in SDF-1 and 42 of 49 cases were positives in CXCR4 with the positive rates of 83.63% and 85.61%,respectively. The expression of SDF-1 and CXCR4 was positively with ER,Her- 2,metastasis of lymphonodes and tumors classification and negtively correlated with 5-years surviving rates. Conclusion SDF-1/CXCR4 and Her-2 expressing high positive is important indicating badly factors of breast cancer in middle-young age groups. SDF-1/CXCR4 as a striking point in promoting metastasis of breast cancers,was a new target of treating breast cancer. The prognosis is worse in case of simultaneous expression of SDF-1/CXCR4,ER and Her-2.
作者 邢大宏
出处 《中国热带医学》 CAS 2010年第3期326-327,364,共3页 China Tropical Medicine
关键词 乳腺肿瘤 浸润性 中青年 SDF-1/CXCR4 Breast cancer Carcinoma Invasion Middle-young age group SDF-1/CXCR4
  • 相关文献

参考文献12

二级参考文献56

共引文献39

同被引文献16

  • 1Taichman RS,Cooper C,Keller ET. Use of the stromal cellderived factor-l/CXCR4 pathway in prostate cancer metastasis to bone[J].Cancer Research,2002,(06):1832-1837.
  • 2Smith I,Procter M,Gelber RD. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer:a randomised controlled trial[J].The Lancet,2007,(9555):29-36.doi:10.1016/S0140-6736(07)60028-2.
  • 3Luker KE,Luker GD. Functions of CXCL12 and CXCR4 in breast cancer[J].Cancer Letters,2006,(01):30-41.
  • 4M(u)ller A,Homey B,Soto H. Involvement of chemokine receptors in breast cancer metastasis[J].Nature,2001,(6824):50-56.doi:10.1038/35065016.
  • 5Dewan MZ,Ahmed S,Iwasaki Y. Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer[J].Biomedicine and Pharmacotherapy,2006,(06):273-276.
  • 6Weng LP,Brown JL,Eng C. PTEN coordinates G(1)arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid posphatase activity in a breast cancer model[J].Human Molecular Genetics,2001,(06):599-604.doi:10.1093/hmg/10.6.599.
  • 7Bose S,Crane A,Hibshoosh H. Reduced expression of PTEN correlates with breast cancer progression[J].Human Pathology,2002,(04):405-409.
  • 8Fernandis AZ,Prasad A,Band H. Regulation of CXCR4-mdeiated chemotaxis and chemoinvasion of breast cancer cells[J].Oncogene,2004,(01):157-167.doi:10.1038/sj.onc.1206910.
  • 9Campbell IG,Russell SE,Choong DY. Mutation of the PIK3CA gene in ovarian and breast cancer[J].Cancer Research,2004,(21):7678-7681.doi:10.1158/0008-5472.CAN-04-2933.
  • 10Gao P,Wange RL,Zhang N. Negative regulation of CXCR4-mediated chemotaxis by the lipid phosphatase activity of tumor suppressor PTEN[J].Blood,2005,(08):2619-2626.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部